AVEO Oncology
MA - BostonBiotechnology
Focus: AVEO Oncology is a Boston-based biotechnology company focused on small-molecule oncology therapeutics. The company operates at a pre-revenue or early-stage clinical development level with minimal public pipeline visibility.
Profile data last refreshed 51m ago · AI intelligence enriched 3w ago
Open Jobs
1
Should You Work at AVEO Oncology?
AI assessmentAVEO is a high-risk, early-stage opportunity suitable only for scientists or development professionals seeking hands-on pipeline roles with tolerance for preclinical-stage uncertainty and limited near-term career mobility.
Why Work Here
- Access to early-stage small-molecule oncology drug development with direct impact on pipeline strategy
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Atezolizumab
Bile Duct CancerClinical Trials (1)
NCT05000294Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Phase 1/2Help build intelligence for AVEO Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.